Pulmonary Research and Innovation :: Nationwide Children's Hospital

Pulmonary Research and Innovation

In addition to providing outstanding clinical care, members of the Section of Pulmonary Medicine conduct research and lead clinical trials to improve patient outcomes.

Nationwide Children’s is part of two large, national research networks through the Cystic Fibrosis Foundation and the American Lung Association.

Pulmonary Clinical Studies

Clinical researchers at Nationwide Children's are committed to identifying new approaches for the prevention, diagnosis and treatment of childhood diseases, taking research discoveries from the lab to the patient's bedside.

Get the Latest

Vidu Garg, MD, Elected to Society of Pediatric Research Council
Three-year term with Society of Pediatric Research Council begins May 2015.

Lung Transplants in CF Patients Most Risky in Late Adolescence
Research confirms a high-risk window for mortality in cystic fibrosis patients receiving lung transplants but struggles to pinpoint the cause.

Studies of Streptococcus pneumoniae Reveal New Therapeutic Targets for Many Diseases
Inhibiting a novel mechanism of bacterial adherence to host cells may prevent colonization of S. pneumoniae and other pathogens.

Pulmonary Sickle Cell Clinic Aims to Reduce Loss to Follow-Up
Adding a dedicated pulmonologist to the existing Comprehensive Sickle Cell and Thalassemia Program may improve patient care.

Stigma Among Cystic Fibrosis Patients Associated With Poor Pulmonary Function
A new study suggests that CF patients who feel stigmatized because of their illness have worse lung function than those with a more positive attitude.

Help for Cystic Fibrosis Patients With GI Problems
A collaboration between pulmonologists and gastrointestinal specialists at Nationwide Children’s offers assistance to cystic fibrosis patients with GI complications.

Bronchoscopy Detects Pathogens in CF Patients Other Tests Miss, Study Finds
Performing a bronchoscopy in CF patients undergoing sinus surgery identifies pathogens that conventional screens failed to detect, according to a new study.

Boosting Immune Process Helps Clear Lethal Bacteria in CF
A new study suggests that boosting a key immune process called autophagy with interferon gamma (IFN-y) could help clear a lethal bacterial infection in cystic fibrosis patients.

Link Between Secondhand Smoke and Growth in CF Patients
A new study suggests that secondhand smoke exposure may slow growth, hinder lung function and increase risk of bacterial infection in infants with cystic fibrosis.

Patients with CF at Increased Risk for Osteoporosis and Osteopenia
Osteoporosis and osteopenia are common in adults and adolescents with cystic fibrosis, according to a new study.

Survival after Lung Transplant
Clinician scientists find pulmonary hypertension doesn’t affect survival after lung transplant in patients with cystic fibrosis.

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000